A Design Approach to Optimise Secure Remote Three-Dimensional (3D) Printing: A Proof-of-Concept Study towards Advancement in Telemedicine
Open Access
- 15 June 2022
- journal article
- research article
- Published by MDPI AG in Healthcare
- Vol. 10 (6) , 1114
Abstract
Telemedicine is defined as the delivery of healthcare services at a distance using electronic means. The incorporation of 3D printing in the telemedicine cycle could result in pharmacists designing and manufacturing personalised medicines based on the electronic prescription received. Even with the advantages of telemedicine, numerous barriers to the uptake hinder the wider uptake. Of particular concern is the cyber risk associated with the remote digital transfer of the computer-aided design (CAD) file (acting as the electronic prescription) to the 3D printer and the reproducibility of the resultant printed medicinal products. This proof-of-concept study aimed to explore the application of secure remote 3D printing of model solid dosage forms using the patented technology, DEFEND3D, which is designed to enhance cybersecurity and intellectual property (IP) protection. The size, shape, and colour of the remote 3D-printed model medicinal products were also evaluated to ensure the end-product quality was user-focused. Thermoplastic polyurethane (TPU) and poly(lactic) acid (PLA) were chosen as model polymers due to their flexibility in preventing breakage printing and ease of printing with fused deposition modelling (FDM). Our work confirmed the potential of secure remote 3D (FDM) printing of prototype solid dosage forms resulting in products with good reproducibility, resolution, and quality towards advancements in telemedicine and digital pharmacies. The limitation of the work presented here was the use of model polymers and not pharmaceutically relevant polymers. Further work could be conducted using the same designs chosen in this study with pharmaceutically relevant polymers used in hot-melt extrusion (HME) with shown suitability for FDM 3D printing. However, it should be noted that any challenges that may occur with pharmaceutically relevant polymers are likely to be related to the polymer’s printability and printer choice as opposed to the ability of the CAD file to be transferred to the printer remotely.Keywords
This publication has 28 references indexed in Scilit:
- Integration of 3D printing with dosage forms: A new perspective for modern healthcareBiomedicine & Pharmacotherapy, 2018
- 3D printed drug delivery and testing systems — a passing fad or the future?Advanced Drug Delivery Reviews, 2018
- Strength of PLA Components Fabricated with Fused Deposition Technology Using a Desktop 3D Printer as a Function of Geometrical Parameters of the ProcessPolymers, 2018
- On the optimization of low-cost FDM 3D printers for accurate replication of patient-specific abdominal aortic aneurysm geometry3D Printing in Medicine, 2018
- FDM 3D Printing of Modified drug-delivery Systems Using Hot Melt extrusion: a New Approach for Individualized TherapyTherapeutic Delivery, 2017
- Patient acceptability of 3D printed medicinesInternational Journal of Pharmaceutics, 2017
- Application of Fused Deposition Modelling (FDM) Method of 3D Printing in Drug DeliveryCurrent Pharmaceutical Design, 2017
- Age-appropriate and acceptable paediatric dosage forms: Insights into end-user perceptions, preferences and practices from the Children’s Acceptability of Oral Formulations (CALF) StudyInternational Journal of Pharmaceutics, 2016
- Accessibility and Vulnerabilty: Ensuring Security of Data in TelemedicineTelemedicine and e-Health, 2015
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric PopulationsDrugs, 2014